Topic Menu
► Topic MenuTopic Editors


Molecular and Cellular Aspects of the Beneficial Effects of Natural Products on Chronic Diseases
Topic Information
Dear Colleagues,
Chronic diseases account for more than 80% of deaths across the globe. They include hypertension, diabetes, cancer, and cardiovascular, kidney, respiratory, and liver diseases and are often characterized by long-term, low-grade inflammation. Chronic diseases share several common risk factors and underlying determinants, such as low physical activity, obesity, poor diet, disturbed sleep patterns, and stress. These common determinants represent opportunities for effective intervention to improve the disease trajectory toward a more favorable course. Natural products are the oldest forms of medication in human history, and bioactive molecules from natural products can still contribute to new drug development today thanks to their broad chemical and functional diversity. Over the past few decades, several studies have demonstrated that the dietary intake of vegetables, fruits, grains, and legumes rich in bioactive compounds such as flavonoids, anthocyanins, procyanidins, and several others can help combat and prevent various chronic conditions. Considering that oxidative stress and chronic inflammation are the hallmarks of several chronic diseases, promising cellular effects of various bioactive molecules are their antioxidant and anti-inflammatory actions. Other promising properties are the anti-lipogenic and anti-diabetic activities for the treatment of metabolic diseases. However, the detailed effects of bioactive natural compounds at the cellular and molecular levels remain largely unknown. The scope of this Topic is to highlight the recent advances and progress made in the mechanisms of action of bioactive natural compounds against chronic diseases. We welcome original research, reviews, and perspective articles describing in vivo, in vitro, and in silico studies. We look forward to receiving your contributions.
Prof. Dr. Claudio Luparello
Dr. Patrizia Bovolin
Topic Editors
Keywords
- chronic diseases
- bioactive natural compounds
- cancer
- metabolic syndrome
- cardiovascular diseases
- liver diseases
- anti-lipogenic
- antioxidant
- anti-inflammatory
- metabolomics/proteomics/transcriptomics
Participating Journals
Journal Name | Impact Factor | CiteScore | Launched Year | First Decision (median) | APC |
---|---|---|---|---|---|
![]()
Biomolecules
|
4.8 | 9.4 | 2011 | 18.4 Days | CHF 2700 |
![]()
Cancers
|
4.5 | 8.0 | 2009 | 17.4 Days | CHF 2900 |
![]()
Diseases
|
2.9 | 0.8 | 2013 | 21.4 Days | CHF 1800 |
![]()
International Journal of Molecular Sciences
|
4.9 | 8.1 | 2000 | 16.8 Days | CHF 2900 |
![]()
Nutrients
|
4.8 | 9.2 | 2009 | 13.5 Days | CHF 2900 |
Preprints.org is a multidisciplinary platform offering a preprint service designed to facilitate the early sharing of your research. It supports and empowers your research journey from the very beginning.
MDPI Topics is collaborating with Preprints.org and has established a direct connection between MDPI journals and the platform. Authors are encouraged to take advantage of this opportunity by posting their preprints at Preprints.org prior to publication:
- Share your research immediately: disseminate your ideas prior to publication and establish priority for your work.
- Safeguard your intellectual contribution: Protect your ideas with a time-stamped preprint that serves as proof of your research timeline.
- Boost visibility and impact: Increase the reach and influence of your research by making it accessible to a global audience.
- Gain early feedback: Receive valuable input and insights from peers before submitting to a journal.
- Ensure broad indexing: Web of Science (Preprint Citation Index), Google Scholar, Crossref, SHARE, PrePubMed, Scilit and Europe PMC.